This year, around 100,000 people in the UK will have a stroke. AI algorithms developed by a University of Oxford spinout company are ensuring that more stroke patients will receive better care and outcomes.
The DETECT study, led by Nuffield Department of Women's and Reproductive Health Professors Christian Becker and Krina Zondervan explores the potential of visualizing endometriosis, including hard-to-detect superficial peritoneal disease, using Serac's innovative imaging agent.
Plans for Warneford Park have taken a step forward as partners in the project signed a Conditional Option Agreement (COA) and Memorandum of Understanding (MOU), agreeing how they will work together going forward.
SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
The BioEscalator recently marked its 5th anniversary with a celebration that showcased the impressive journeys of some of its current and graduated biotech companies.
As the COVID-19 pandemic demonstrated, viruses can quickly evolve new ways of evading our immune systems, undermining our efforts to control outbreaks. But a new artificial intelligence (AI) tool developed by researchers at the University of Oxford and Harvard Medical School could help predict new viral variants before they emerge. The findings have been published in the journal Nature.
An academic/industry partnership, based at the NIHR Oxford Health Biomedical Research Centre, is helping companies use experimental medicine approaches to speed up development of new drugs to treat psychiatric disorders.
A team of researchers from the University of Oxford has shown for the first time that it is possible to track the progression of Parkinson\u2019s Disease accurately using specially trained machine learning algorithms to analyse data derived from sensor devices worn by patients.
A breakthrough technique developed by University of Oxford researchers could one day provide tailored repairs for those who suffer brain injuries. The researchers demonstrated for the first time that neural cells can be 3D printed to mimic the architecture of the cerebral cortex. These results have been published today in the journal Nature Communications.
The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.
The UK\u2019s first Space Innovation Lab, dedicated to understanding the effect of space microgravity on the ageing process, opens at the Botnar Institute today.
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive \u00a396 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
The University of Oxford has held its position as the leading academic institution in the UK for generating spinout companies, according to a new report by data analyst firm Beauhurst.
Mental Health and Dementia are a global healthcare crisis, affecting over one billion people worldwide. Of those, over 400 million people are on the Alzheimer's disease continuum, with one person diagnosed every three seconds, and the figure expected to rise as the global population of those over 60 is set to double by 2050.
Nearly one billion people worldwide suffer from some form of mental disorder, according to UN data, but relatively few can access the treatment they need. Innovative AI based therapy, developed by researchers at Oxford, is now enabling a greater number of people to get help.
The University of Oxford has partnered with other institutions and investors to agree terms which will greatly increase the UK\u2019s capacity to turn world-leading research into spinouts that will generate economic growth and societal impact.
![\"Brainomix](\"https://www.medsci.ox.ac.uk/news/oxford-spinout-brainomix-is-revolutionising-stroke-care-through-ai/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n